{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:26:39Z","timestamp":1793931999441,"version":"4.8.0"},"reference-count":298,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["1026-00335B"],"award-info":[{"award-number":["1026-00335B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R277-2018-260"],"award-info":[{"award-number":["R277-2018-260"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0067835"],"award-info":[{"award-number":["NNF21OC0067835"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pharmr.2025.100064","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:27:17Z","timestamp":1746473237000},"page":"100064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["International Union of Basic and Clinical Pharmacology. CXX. \u03b3-Hydroxybutyrate protein targets in the mammalian brain\u2014beyond classic receptors"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-8013","authenticated-orcid":false,"given":"Petrine","family":"Wellendorph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3017-0962","authenticated-orcid":false,"given":"Stine Juul","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-2675","authenticated-orcid":false,"given":"Jens Velde","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-9451","authenticated-orcid":false,"given":"Birgitte Rahbek","family":"Kornum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.O.","family":"Solbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Fr\u00f8lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2025.100064_bib1","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1073\/pnas.1204376109","article-title":"\u03b14\u03b2\u03b4 GABAA receptors are high-affinity targets for \u03b3-hydroxybutyric acid (GHB)","volume":"109","author":"Absalom","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106386","article-title":"ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations","volume":"190","author":"Afshar-Saber","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.128.3320.359.b","article-title":"Succinic semialdehyde oxidation by a soluble dehydrogenase from brain","volume":"128","author":"Albers","year":"1958","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.pharmr.2025.100064_bib4","first-page":"S23","article-title":"The concise guide to Pharmacology 2023\/24: G protein-coupled receptors","volume":"180","author":"Alexander","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib5","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/jxb\/ern122","article-title":"Gamma-hydroxybutyrate accumulation in Arabidopsis and tobacco plants is a general response to abiotic stress: putative regulation by redox balance and glyoxylate reductase isoforms","volume":"59","author":"Allan","year":"2008","journal-title":"J Exp Botany"},{"key":"10.1016\/j.pharmr.2025.100064_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100543","article-title":"N-Terminomic changes in neurons during excitotoxicity reveal proteolytic events associated with synaptic dysfunctions and potential targets for neuroprotection","volume":"22","author":"Ameen","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.pharmr.2025.100064_bib7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/glia.23872","article-title":"Extensive astrocyte metabolism of \u03b3-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex","volume":"68","author":"Andersen","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.pharmr.2025.100064_bib8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/glia.24585","article-title":"Deficient brain GABA metabolism leads to widespread impairments of astrocyte and oligodendrocyte function","volume":"72","author":"Andersen","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.pharmr.2025.100064_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s11064-022-03771-1","article-title":"Glial glutamine homeostasis in health and disease","volume":"48","author":"Andersen","year":"2023","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jnc.15811","article-title":"Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission\u2014the essential roles of astrocytes","volume":"166","author":"Andersen","year":"2023","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/EBC20220208","article-title":"Astrocytes regulate inhibitory neurotransmission through GABA uptake, metabolism, and recycling","volume":"67","author":"Andersen","year":"2023","journal-title":"Essays Biochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1471-4159.1977.tb10435.x","article-title":"Formation of gamma-hydroxybutyrate in brain","volume":"28","author":"Anderson","year":"1977","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1096\/fj.06-6509com","article-title":"Cloning and functional characterization of a \u03b3-hydroxybutyrate receptor identified in the human brain","volume":"21","author":"Andriamampandry","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2025.100064_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1096\/fj.02-0846fje","article-title":"Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator \u03b3-hydroxybutyrate (GHB)","volume":"17","author":"Andriamampandry","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2025.100064_bib15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1471-4159.1992.tb10049.x","article-title":"Ischemia-induced translocation of Ca2+\/calmodulin-dependent protein kinase II: potential role in neuronal damage","volume":"58","author":"Aronowski","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41586-021-03465-8","article-title":"Comparative cellular analysis of motor cortex in human, marmoset and mouse","volume":"598","author":"Bakken","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100064_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/bj1160445","article-title":"The operation of the gamma-aminobutyrate bypath of the tricarboxylic acid cycle in brain tissue in vitro","volume":"116","author":"Balazs","year":"1970","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100064_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0306-4522(93)90557-V","article-title":"\u03b3-Hydroxybutyric acid induced spike and wave discharges in rats: relation to high-affinity [3H] \u03b3-hydroxybutyric acid binding sites in the thalamus and cortex","volume":"56","author":"Banerjee","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2025.100064_bib19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0022-3565(25)09686-7","article-title":"Presynaptic \u03b3-hydroxybutyric acid (GHB) and \u03b3-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB","volume":"273","author":"Banerjee","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00216-007-1486-6","article-title":"Quantitative mass spectrometry in proteomics: a critical review","volume":"389","author":"Bantscheff","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy\u2014clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmr.2025.100064_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13387","article-title":"European guideline and expert statements on the management of narcolepsy in adults and children","volume":"30","author":"Bassetti","year":"2021","journal-title":"J Sleep Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcp.2013.10.028","article-title":"GHB receptor targets in the CNS: Focus on high-affinity binding sites","volume":"87","author":"Bay","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/35081080","article-title":"Interaction with the NMDA receptor locks CaMKII in an active conformation","volume":"411","author":"Bayer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100064_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1523\/JNEUROSCI.3116-05.2006","article-title":"Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B","volume":"26","author":"Bayer","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(99)00131-X","article-title":"Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system","volume":"70","author":"Bayer","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2019.05.033","article-title":"CaM Kinase: Still Inspiring at 40","volume":"103","author":"Bayer","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","article-title":"High affinity binding sites for \u03b3-hydroxybutyric acid in rat brain","volume":"30","author":"Benavides","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1471-4159.1982.tb06634.x","article-title":"A high-affinity, Na+-dependent uptake system for \u03b3-hydroxybutyrate in membrane vesicles prepared from rat brain","volume":"38","author":"Benavides","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/01.wnl.0000239827.38036.23","article-title":"Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity","volume":"67","author":"Bensmail","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100064_bib31","first-page":"155","article-title":"Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors","volume":"35","author":"Bernasconi","year":"1992","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pharmr.2025.100064_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-6147(99)01341-3","article-title":"Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?","volume":"20","author":"Bernasconi","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/2001207a0","article-title":"\u03b3-Hydroxybutyrate, a normal brain metabolite","volume":"200","author":"Bessman","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100064_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0021-9258(18)71381-1","article-title":"Gamma-Aminobutyric acid-glutamic acid transamination in brain","volume":"201","author":"Bessman","year":"1953","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib35","article-title":"GABAB receptors in GtoPdb v.2021.2","volume":"2","author":"Bettler","year":"2021","journal-title":"IUPHAR\/BPS Guide to Pharmacology CITE"},{"key":"10.1016\/j.pharmr.2025.100064_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABAB receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2025.100064_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40263-020-00730-8","article-title":"Tapering with pharmaceutical GHB or benzodiazepines for detoxification in GHB-dependent patients: a matched-subject observational study of treatment-as-usual in Belgium and The Netherlands","volume":"34","author":"Beurmanjer","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmr.2025.100064_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.104.069682","article-title":"GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier","volume":"311","author":"Bhattacharya","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035147","article-title":"Structural insights into the regulation of Ca2+\/calmodulin-dependent protein kinase II (CaMKII)","volume":"12","author":"Bhattacharyya","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.pharmr.2025.100064_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13405","article-title":"Molecular mechanism of activation-triggered subunit exchange in Ca2+\/calmodulin-dependent protein kinase II","volume":"5","author":"Bhattacharyya","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100064_bib41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.sleep.2009.05.004","article-title":"The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy","volume":"10","author":"Black","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.pharmr.2025.100064_bib42","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1523\/JNEUROSCI.0080-14.2014","article-title":"GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy","volume":"34","author":"Black","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0741-8329(99)00086-5","article-title":"Design and structure-activity relationship analysis of ligands of \u03b3-hydroxybutyric acid receptors","volume":"20","author":"Bourguignon","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmr.2025.100064_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/jat\/bkw107","article-title":"Increases in serum growth hormone concentrations associated with GHB administration","volume":"41","author":"Brailsford","year":"2017","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharmr.2025.100064_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113982","article-title":"Studying CaMKII: tools and standards","volume":"43","author":"Brown","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2025.100064_bib46","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1017\/S0033583522000129","article-title":"Nobel prize 2022 to sharpless, meldal, bertozzi click chemistry\u2014molecular lego","volume":"55","author":"Brown","year":"2022","journal-title":"Q Rev Biophys"},{"key":"10.1016\/j.pharmr.2025.100064_bib47","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1762-23.2024","article-title":"TRPM2 and CaMKII signaling drives excessive GABAergic synaptic inhibition following ischemia","volume":"44","author":"Burch","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","article-title":"GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome","volume":"13","author":"Busardo","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABAB receptors in the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/jpet.102.047860","article-title":"The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies","volume":"305","author":"Carter","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2008.10.003","article-title":"Behavioral analyses of GHB: receptor mechanisms","volume":"121","author":"Carter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","article-title":"Illicit \u03b3-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse","volume":"104","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2025.100064_bib53","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/jpet.104.077578","article-title":"Novel \u03b3-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists","volume":"313","author":"Carter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(96)12589-1","article-title":"Kinetic characterisation and solubilisation of \u03b3-hydroxybutyrate receptors from rat brain","volume":"209","author":"Cash","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-4159.1979.tb05261.x","article-title":"Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hydroxybutyrate","volume":"33","author":"Cash","year":"1979","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0005-2744(78)90099-2","article-title":"Purification and properties of two succinate semialdehyde dehydrogenases from human brain","volume":"524","author":"Cash","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100064_bib57","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2174\/138955708786141025","article-title":"Multi-faceted aspects of \u03b3-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse","volume":"8","author":"Castelli","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib58","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","article-title":"Selective \u03b3-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid","volume":"87","author":"Castelli","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-328X(00)00078-4","article-title":"Quantitative autoradiographic distribution of \u03b3-hydroxybutyric acid binding sites in human and monkey brain","volume":"78","author":"Castelli","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1527-3458.2004.tb00025.x","article-title":"A review of pharmacology of NCS-382, a putative antagonist of \u03b3-hydroxybutyric acid (GHB) receptor","volume":"10","author":"Castelli","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmr.2025.100064_bib61","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1038\/s41467-019-10694-z","article-title":"Mechanisms of Ca(2+)\/calmodulin-dependent kinase II activation in single dendritic spines","volume":"10","author":"Chang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100064_bib62","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.07.038","article-title":"A mechanism for tunable autoinhibition in the structure of a human Ca2+\/calmodulin-dependent kinase II holoenzyme","volume":"146","author":"Chao","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100064_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32451","article-title":"A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability","volume":"7","author":"Chia","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100064_bib64","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.15-04-03200.1995","article-title":"Excitotoxic activation of the NMDA receptor results in inhibition of calcium\/calmodulin kinase II activity in cultured hippocampal neurons","volume":"15","author":"Churn","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.STR.21.12.1715","article-title":"Effects of ischemia on multifunctional calcium\/calmodulin-dependent protein kinase type II in the gerbil","volume":"21","author":"Churn","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.pharmr.2025.100064_bib66","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1016\/S0021-9258(18)53160-4","article-title":"Inactivation of Ca2+\/calmodulin-dependent protein kinase II by basal autophosphorylation","volume":"268","author":"Colbran","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib67","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1016\/S0021-9258(18)83661-4","article-title":"Regulatory domain of calcium\/calmodulin-dependent protein kinase II. Mechanism of inhibition and regulation by phosphorylation","volume":"264","author":"Colbran","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079062","article-title":"\u03b3-Hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors","volume":"8","author":"Connelly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100064_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2300","article-title":"CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision","volume":"7","author":"Cook","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2025.100064_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/aps.2011.68","article-title":"CaMKII in cerebral ischemia","volume":"32","author":"Coultrap","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmr.2025.100064_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","article-title":"Unravelling the brain targets of \u03b3-hydroxybutyric acid","volume":"6","author":"Crunelli","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib72","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/brain\/awaa072","article-title":"Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures","volume":"143","author":"Crunelli","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2025.100064_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn1181","article-title":"Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system","volume":"7","author":"Cruz","year":"2004","journal-title":"Nature Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1471-4159.1980.tb04640.x","article-title":"Oxidative metabolism of 4-aminobutyrate by rat brain mitochondria: inhibition by branched-chain fatty acid","volume":"34","author":"Cunningham","year":"1980","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejmech.2017.06.024","article-title":"Monastrol, a 3,4-dihydropyrimidin-2(1H)-thione, as structural scaffold for the development of modulators for GHB high-affinity binding sites and \u03b11\u03b22\u03b4 GABAA receptors","volume":"138","author":"Damgaard","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/223074a0","article-title":"Content and release of amino-acids and catecholamines in monkey brain","volume":"223","author":"DeFeudis","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100064_bib77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.celrep.2017.01.011","article-title":"Autonomous CaMKII activity as a drug target for histological and functional neuroprotection after resuscitation from cardiac arrest","volume":"18","author":"Deng","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2025.100064_bib78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2016.11.014","article-title":"Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: the Dutch GHB monitor project","volume":"170","author":"Dijkstra","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2025.100064_bib79","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0197-0186(00)00061-9","article-title":"Glutamate-mediated transmission, alcohol, and alcoholism","volume":"37","author":"Dodd","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-3565(25)31400-X","article-title":"Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain","volume":"207","author":"Doherty","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib81","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1471-4159.1978.tb10460.x","article-title":"Metabolism of gamma-hydroxy-[1-14C] butyrate by rat brain: relationship to the Krebs cycle and metabolic compartmentation of amino acids","volume":"30","author":"Doherty","year":"1978","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib82","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s10545-008-0941-7","article-title":"SSADH deficiency leads to elevated extracellular GABA levels and increased GABAergic neurotransmission in the mouse cerebral cortex","volume":"31","author":"Drasbek","year":"2008","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib83","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejphar.2014.06.028","article-title":"Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin","volume":"740","author":"Eghorn","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-4159.1983.tb04770.x","article-title":"Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism","volume":"41","author":"Eli","year":"1983","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(96)13016-0","article-title":"Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors","volume":"216","author":"Emri","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib86","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1073\/pnas.1138025100","article-title":"Identification of receptors for pig endogenous retrovirus","volume":"100","author":"Ericsson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib87","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1523\/JNEUROSCI.05-12-03270.1985","article-title":"Regional distribution of type II Ca2+\/calmodulin-dependent protein kinase in rat brain","volume":"5","author":"Erondu","year":"1985","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib88","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/00001756-200107200-00039","article-title":"Baclofen antagonises intravenous self-administration of \u03b3-hydroxybutyric acid in mice","volume":"12","author":"Fattore","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmr.2025.100064_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1208\/s12248-020-00543-z","article-title":"\u03b3-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology","volume":"23","author":"Felmlee","year":"2021","journal-title":"AAPS J"},{"key":"10.1016\/j.pharmr.2025.100064_bib90","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1471-4159.2001.00530.x","article-title":"\u03b3-Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study","volume":"78","author":"Ferraro","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib91","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-827X(03)00018-1","article-title":"Ligands for expression cloning and isolation of GABA(B) receptors","volume":"58","author":"Froestl","year":"2003","journal-title":"Farmaco"},{"key":"10.1016\/j.pharmr.2025.100064_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0741-8329(99)00089-0","article-title":"Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence","volume":"20","author":"Gallimberti","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmr.2025.100064_bib93","first-page":"89","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2025.100064_bib94","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000151683","article-title":"Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia","volume":"26","author":"Gao","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108543","article-title":"Allosteric factors in the calcium\/ calmodulin-responsive kinase II hub domain determine selectivity of GHB ligands for CaMKII\u03b1","author":"Gauger","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrn3249","article-title":"Regulation of neuronal GABA(B) receptor functions by subunit composition","volume":"13","author":"Gassmann","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib97","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1523\/JNEUROSCI.23-36-11469.2003","article-title":"Pathway-specific action of \u03b3-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures","volume":"23","author":"Gervasi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib98","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/0024-3205(66)90261-X","article-title":"Selective increase of brain dopamine induced by \u03b3-hydroxybutyrate","volume":"5","author":"Gessa","year":"1966","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib99","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.145.3632.583","article-title":"Differential estimation of \u03b3-butyrolactone and \u03b3-hydroxybutyric acid in rat blood and brain","volume":"145","author":"Giarman","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100064_bib100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.99.4.567","article-title":"The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients","volume":"99","author":"Gibson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmr.2025.100064_bib101","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(89)91126-4","article-title":"Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency","volume":"2","author":"Gibson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100064_bib102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00711750","article-title":"Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency","volume":"18","author":"Gibson","year":"1995","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(83)90018-9","article-title":"Succinic semialdehyde dehydrogenase deficiency: an inborn error of \u03b3-aminobutyric acid metabolism","volume":"133","author":"Gibson","year":"1983","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmr.2025.100064_bib104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3565(24)34899-2","article-title":"\u03b3-Hydroxybutyrate modulates synthesis and extracellular concentration of \u03b3-aminobutyric acid in discrete rat brain regions in vivo","volume":"290","author":"Gobaille","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib105","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0607","article-title":"GABAB receptor-mediated activation of astrocytes by \u03b3-hydroxybutyric acid","volume":"369","author":"Gould","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib106","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/brainsci12121639","article-title":"CaMKI\u0399\u03b1 as a promising drug target for ischemic grey matter","volume":"12","author":"Griem-Krey","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jlcr.3870","article-title":"Radiolabeled HOCPCA as a highly useful tool in drug discovery and pharmacology","volume":"64","author":"Griem-Krey","year":"2020","journal-title":"J Labl Comp Radiopharm"},{"key":"10.1016\/j.pharmr.2025.100064_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113895","article-title":"The CaMKII\u03b1 hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction","volume":"156","author":"Griem-Krey","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100064_bib109","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/0271678X231167920","article-title":"The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIa","volume":"43","author":"Griem-Krey","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib110","doi-asserted-by":"crossref","DOI":"10.3791\/58879","article-title":"Autoradiography as a simple and powerful method for visualization and characterization of pharmacological targets","author":"Griem-Krey","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.pharmr.2025.100064_bib111","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.302.1.180","article-title":"Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria)","volume":"302","author":"Gupta","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib112","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2008.04.040","article-title":"Ischemia and status epilepitcus result in enhanced phosphorylation of calcium and calmodulin-stimulated protein kinase II on threonine 253","volume":"1218","author":"Gurd","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib113","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/jcbfm.1990.91","article-title":"Effect of \u03b3-hydroxybutyrate on local and global glucose metabolism in the anesthetized cat brain","volume":"10","author":"Haller","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib114","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1016\/S0021-9258(18)41915-1","article-title":"Inhibitory autophosphorylation of multifunctional Ca2+\/calmodulin-dependent protein kinase analyzed by site-directed mutagenesis","volume":"267","author":"Hanson","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.STR.25.2.466","article-title":"Calcium\/calmodulin-dependent protein kinase II activity in focal ischemia with reperfusion in rats","volume":"25","author":"Hanson","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.pharmr.2025.100064_bib116","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1016\/S0021-9258(18)47525-4","article-title":"Autophosphorylation of Ca2+\/calmodulin-dependent protein kinase II. Effects on total and Ca2+-independent activities and kinetic parameters","volume":"262","author":"Hashimoto","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib117","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms24054334","article-title":"Neuroprotective strategies for ischemic stroke-future perspectives","volume":"24","author":"Haupt","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib118","doi-asserted-by":"crossref","first-page":"11459","DOI":"10.1016\/S0021-9258(18)90883-5","article-title":"Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes","volume":"259","author":"Hearl","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00964607","article-title":"\u03b3-Hydroxybutyrate uptake by rat brain striatal slices","volume":"10","author":"Hechler","year":"1985","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib120","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-4159.1991.tb02012.x","article-title":"Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study","volume":"56","author":"Hechler","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib121","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(92)90498-X","article-title":"Selective distribution pattern of \u03b3-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography","volume":"572","author":"Hechler","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib122","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)36673-X","article-title":"\u03b3-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide","volume":"281","author":"Hechler","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib123","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0304-3940(90)90812-N","article-title":"Trans-\u03b3-hydroxycrotonic acid binding sites in brain: evidence for a subpopulation of \u03b3-hydroxybutyrate sites","volume":"110","author":"Hechler","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib124","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.1987.tb09990.x","article-title":"Regional distribution of high-affinity \u03b3-[3H]hydroxybutyrate binding sites as determined by quantitative autoradiography","volume":"49","author":"Hechler","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y","article-title":"Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum","volume":"426","author":"Hedou","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmr.2025.100064_bib126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/290149a0","article-title":"3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain","volume":"290","author":"Hill","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100064_bib127","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1097-2765(03)00171-0","article-title":"Crystal structure of a tetradecameric assembly of the association domain of Ca2+\/calmodulin-dependent kinase II","volume":"11","author":"Hoelz","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmr.2025.100064_bib128","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/jm801112u","article-title":"Novel high-affinity and selective biaromatic 4-substituted \u03b3-hydroxybutyric acid (GHB) analogues as GHB ligands: design, synthesis, and binding studies","volume":"51","author":"H\u00f8g","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(83)90440-8","article-title":"Action of gamma-hydroxybutyrate and GABA on neurones of cultured rat central nervous system","volume":"37","author":"H\u00f6sli","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0028-3908(99)00152-5","article-title":"Regulation of \u03b3-aminobutyric acid (GABA) release in cerebral cortex in the \u03b3-hydroxybutyric acid (GHB) model of absence seizures in rat","volume":"39","author":"Hu","year":"2000","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2009.02.008","article-title":"Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate","volume":"41","author":"Huang","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pharmr.2025.100064_bib132","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1074\/jbc.271.15.8800","article-title":"Inactivation and self-association of Ca2+\/calmodulin-dependent protein kinase II during autophosphorylation","volume":"271","author":"Hudmon","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib133","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj20020228","article-title":"Structure-function of the multifunctional Ca2+\/calmodulin-dependent protein kinase II","volume":"364","author":"Hudmon","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100064_bib134","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cell.2005.11.017","article-title":"CaMKII structure\u2014an elegant design","volume":"123","author":"Hunter","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100064_bib135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","article-title":"The conformational plasticity of protein kinases","volume":"109","author":"Huse","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100064_bib136","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1126\/science.1585175","article-title":"Solution structure of a calmodulin-target peptide complex by multidimensional NMR","volume":"256","author":"Ikura","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100064_bib137","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0140-6736(89)92466-5","article-title":"Vigabatrin in GABA metabolism disorders","volume":"1","author":"Jaeken","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100064_bib138","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(81)90184-4","article-title":"Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism","volume":"111","author":"Jakobs","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmr.2025.100064_bib139","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acschemneuro.6b00335","article-title":"Radiosynthesis and evaluation of [11C]3-hydroxycyclopent-1-enecarboxylic acid as potential PET ligand for the high-affinity \u03b3-hydroxybutyric acid binding sites","volume":"8","author":"Jensen","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40263-016-0402-z","article-title":"Pharmacological treatment in \u03b3-hydroxybutyrate (GHB) and \u03b3-butyrolactone (GBL) dependence: detoxification and relapse prevention","volume":"31","author":"Kamal","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmr.2025.100064_bib141","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.03.035","article-title":"The importance of a good night's sleep: an open-label trial of the sodium salt of \u03b3-hydroxybutyric acid in insomnia associated with schizophrenia","volume":"120","author":"Kantrowitz","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib142","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57784","article-title":"Breakage of the oligomeric CaMKII hub by the regulatory segment of the kinase","volume":"9","author":"Karandur","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100064_bib143","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF00965839","article-title":"An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP+-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway","volume":"16","author":"Kaufman","year":"1991","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib144","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","article-title":"Specific \u03b3-hydroxybutyrate-binding sites but loss of pharmacological effects of \u03b3-hydroxybutyrate in GABAB(1)-deficient mice","volume":"18","author":"Kaupmann","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad156","article-title":"The mystery of \u03b3-hydoxybutyrate efficacy in narcolepsy type 1","volume":"46","author":"Kilduff","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.pharmr.2025.100064_bib146","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11011-020-00550-1","article-title":"Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes","volume":"35","author":"Kirby","year":"2020","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib147","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuint.2016.09.002","article-title":"Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using 3H-HOCPCA","volume":"100","author":"Klein","year":"2016","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045323","article-title":"Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability","volume":"7","author":"Klug","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100064_bib149","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/jpet.103.056093","article-title":"Discriminative stimulus effects of \u03b3-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABAA and GABAB receptors","volume":"308","author":"Koek","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of \u03b3-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.pharmr.2025.100064_bib151","doi-asserted-by":"crossref","first-page":"31555","DOI":"10.1074\/jbc.273.47.31555","article-title":"Identification of domains essential for the assembly of calcium\/calmodulin-dependent protein kinase II holoenzymes","volume":"273","author":"Kolb","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib152","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1074\/jbc.275.19.14354","article-title":"Three-dimensional reconstructions of calcium\/calmodulin-dependent (CaM) kinase IIalpha and truncated CaM kinase IIalpha reveal a unique organization for its structural core and functional domains","volume":"275","author":"Kolodziej","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pharmr.2025.100064_bib154","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1021\/acs.jmedchem.9b00131","article-title":"Discovery of 2-(Imidazo[1,2- b]pyridazin-2-yl)acetic acid as a new class of ligands selective for the g-hydroxybutyric acid (GHB) high-affinity binding sites","volume":"62","author":"Krall","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib155","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1021\/acs.jmedchem.7b01351","article-title":"Molecular hybridization of potent and selective \u03b3-hydroxybutyric acid (GHB) ligands: design, synthesis, binding studies, and molecular modeling of novel 3-hydroxycyclopent-1-enecarboxylic acid (HOCPCA) and trans-\u03b3-hydroxycrotonic acid (T-HCA) analogs","volume":"60","author":"Krall","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib156","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.STR.0000126118.44249.5c","article-title":"Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us?","volume":"35","author":"Krieger","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.pharmr.2025.100064_bib157","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-009-1562-z","article-title":"The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progress","volume":"205","author":"Kumar","year":"2009","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.pharmr.2025.100064_bib158","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ajhg.2017.10.003","article-title":"De novo mutations in protein kinase genes CAMK2A and CAMK2B cause intellectual disability","volume":"101","author":"K\u00fcry","year":"2017","journal-title":"Am J Hum Gen"},{"key":"10.1016\/j.pharmr.2025.100064_bib159","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0028-3908(64)90074-7","article-title":"Sodium 4-hydroxybutyrate","volume":"3","author":"Laborit","year":"1964","journal-title":"Int J Neuropharm"},{"key":"10.1016\/j.pharmr.2025.100064_bib160","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn2006","article-title":"RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area","volume":"10","author":"Labouebe","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib161","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1073\/pnas.83.12.4253","article-title":"Autophosphorylation reversibly regulates the Ca2+\/calmodulin-dependence of Ca2+\/calmodulin-dependent protein kinase II","volume":"83","author":"Lai","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib162","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/NSS.S86649","article-title":"Baclofen for narcolepsy with cataplexy: two cases","volume":"7","author":"Lee","year":"2015","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.pharmr.2025.100064_bib163","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211572119","article-title":"Synaptic memory survives molecular turnover","volume":"119","author":"Lee","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib164","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","volume":"2","author":"Leone","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2025.100064_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108079118","article-title":"GHB analogs confer neuroprotection through specific interaction with the CaMKII\u03b1 hub domain","volume":"118","author":"Leurs","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib166","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1016\/S0021-9258(18)37414-3","article-title":"Regulation of Ca2+\/calmodulin-dependent protein kinase II by Ca2+\/calmodulin-independent autophosphorylation","volume":"263","author":"Lickteig","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib167","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"\u03b3-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors","volume":"38","author":"Lingenhoehl","year":"1999","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib168","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib169","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1074\/jbc.M806409200","article-title":"Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib170","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1073\/pnas.83.24.9497","article-title":"Activation of the multifunctional Ca2+\/calmodulin-dependent protein kinase by autophosphorylation: ATP modulates production of an autonomous enzyme","volume":"83","author":"Lou","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib171","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1523\/JNEUROSCI.09-06-02020.1989","article-title":"Distinct autophosphorylation sites sequentially produce autonomy and inhibition of the multifunctional Ca2+\/calmodulin-dependent protein kinase","volume":"9","author":"Lou","year":"1989","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib172","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86090","article-title":"CaMKII autophosphorylation can occur between holoenzymes without subunit exchange","volume":"12","author":"Lucic","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100064_bib173","doi-asserted-by":"crossref","first-page":"25986","DOI":"10.1074\/jbc.M702465200","article-title":"Synthesis and catabolism of \u03b3-hydroxybutyrate in SH-SY5Y human neuroblastoma cells: role of the aldo-keto reductase AKR7A2","volume":"282","author":"Lyon","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib174","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The \u03b3-hydroxybutyrate signalling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100064_bib175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.1983.tb11843.x","article-title":"Depolarization-evoked release of gamma-hydroxybutyrate from rat brain slices","volume":"41","author":"Maitre","year":"1983","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib176","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3565(25)23017-8","article-title":"A specific \u03b3-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties","volume":"255","author":"Maitre","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib177","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-016-0205-y","article-title":"A proposed preventive role for gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer's disease","volume":"8","author":"Maitre","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib178","first-page":"441","article-title":"High affinity binding site for \u03b3-hydroxybutyric acid in rat brain","volume":"37","author":"Maitre","year":"1983","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib179","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0006-291X(83)91289-5","article-title":"Subcellular distribution of \u03b3-hydroxybutyrate binding sites in rat brain principal localization in the synaptosomal fraction","volume":"110","author":"Maitre","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100064_bib180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0149-7634(89)80053-3","article-title":"Gammahydroxybutyrate: an endogenous regulator of energy metabolism","volume":"13","author":"Mamelak","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmr.2025.100064_bib181","doi-asserted-by":"crossref","first-page":"20559","DOI":"10.1073\/pnas.1010346107","article-title":"Selective translocation of Ca2+\/calmodulin protein kinase IIalpha (CaMKII\u03b1) to inhibitory synapses","volume":"107","author":"Marsden","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(96)00916-8","article-title":"Binding characteristics of \u03b3-hydroxybutyric acid as a weak but selective GABAB receptor agonist","volume":"321","author":"Mathivet","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib183","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00004647-200209000-00008","article-title":"Persistent phosphorylation of synaptic proteins following middle cerebral artery occlusion","volume":"22","author":"Matsumoto","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib184","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.WCB.0000095920.70924.F5","article-title":"Protein kinase C-gamma and calcium\/calmodulin-dependent protein kinase II-alpha are persistently translocated to cell membranes of the rat brain during and after middle cerebral artery occlusion","volume":"24","author":"Matsumoto","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000028233","article-title":"Inhibitors of synaptosomal \u03b3-hydroxybutyrate transport","volume":"57","author":"McCormick","year":"1998","journal-title":"Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib186","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pro.3614","article-title":"Variation in assembly stoichiometry in non-metazoan homologs of the hub domain of Ca2+\/calmodulin-dependent protein kinase II","volume":"28","author":"McSpadden","year":"2019","journal-title":"Protein Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib187","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.1519061","article-title":"Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex","volume":"257","author":"Meador","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100064_bib188","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.8259515","article-title":"Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures","volume":"262","author":"Meador","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100064_bib189","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)29240-5","article-title":"Binding characteristics of the \u03b3-hydroxybutyric acid receptor antagonist [3H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain","volume":"299","author":"Mehta","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib190","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1019844518704","article-title":"Phosphorylation state, solubility, and activity of calcium\/calmodulin-dependent protein kinase II alpha in transient focal ischemia in mouse brain","volume":"27","author":"Mengesdorf","year":"2002","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib191","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0092-8674(86)90008-5","article-title":"Regulation of brain type II Ca2+\/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch","volume":"44","author":"Miller","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100064_bib192","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0896-6273(88)90109-2","article-title":"Sequences of autophosphorylation sites in neuronal type II CaM kinase that control Ca2+-independent activity","volume":"1","author":"Miller","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib193","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-6147(99)01323-1","article-title":"GABAB receptors make it to the top - as dimers","volume":"20","author":"M\u00f6hler","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib194","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1471-4159.1976.tb01572.x","article-title":"Gamma-hydroxybutyrate degradation in the brain in vivo: negligible direct conversion to GABA","volume":"27","author":"Mohler","year":"1976","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2018.10.020","article-title":"Management of excessive daytime sleepiness in narcolepsy with baclofen","volume":"93","author":"Morse","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pharmr.2025.100064_bib196","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib197","doi-asserted-by":"crossref","first-page":"13744","DOI":"10.1016\/S0021-9258(17)36708-X","article-title":"Regulation of Ca2+\/calmodulin-dependent protein kinase II by inter- and intrasubunit-catalyzed autophosphorylations","volume":"269","author":"Mukherji","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib198","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.0022-3042.2002.00780.x","article-title":"Evidence for a \u03b3-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles","volume":"80","author":"Muller","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15742","article-title":"The CaMKII holoenzyme structure in activation-competent conformations","volume":"8","author":"Myers","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100064_bib200","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5152","article-title":"Ligand-induced CaMKIIalpha hub Trp403 flip, hub domain stacking, and modulation of kinase activity","volume":"33","author":"Narayanan","year":"2024","journal-title":"Protein Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib201","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1152\/physrev.00034.2022","article-title":"Synaptic memory and CaMKII","volume":"103","author":"Nicoll","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2025.100064_bib202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/syn.890170402","article-title":"Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux","volume":"17","author":"Nissbrandt","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.pharmr.2025.100064_bib203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(79)90071-4","article-title":"Fine structural localization of glutamine synthetase in astrocytes of rat brain","volume":"161","author":"Norenberg","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib204","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tins.2006.08.004","article-title":"Astrocytic complexity distinguishes the human brain","volume":"29","author":"Oberheim","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120881","article-title":"Excitotoxic insult results in a long-lasting activation of CaMKIIalpha and mitochondrial damage in living hippocampal neurons","volume":"10","author":"Otmakhov","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100064_bib206","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(03)03252-9","article-title":"Effect of \u03b3-hydroxybutyrate in two rat models of focal cerebral damage","volume":"986","author":"Ottani","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib207","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2003.11.072","article-title":"Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat","volume":"485","author":"Ottani","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111064","article-title":"CaMKII binds both substrates and activators at the active site","volume":"40","author":"Ozden","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2025.100064_bib209","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/01.WNL.0000059549.70717.80","article-title":"Clinical spectrum of succinic semialdehyde dehydrogenase deficiency","volume":"60","author":"Pearl","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100064_bib210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(01)02897-9","article-title":"Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease","volume":"916","author":"Picklo","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","article-title":"Monocarboxylate transporters in the central nervous system: distribution, regulation and function","volume":"94","author":"Pierre","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib212","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib213","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40261-021-01038-1","article-title":"Riboflavin in neurological diseases: a narrative review","volume":"41","author":"Plantone","year":"2021","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.pharmr.2025.100064_bib214","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/humu.23647","article-title":"The intellectual disability-associated CAMK2G p.Arg292Pro mutation acts as a pathogenic gain-of-function","volume":"39","author":"Proietti Onori","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmr.2025.100064_bib215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0705447","article-title":"Effects of GABA agonists on body temperature regulation in GABAB(1)-\/- mice","volume":"140","author":"Qu\u00e9va","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib216","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(95)11434-X","article-title":"\u03b3-Hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin","volume":"189","author":"Ratomponirina","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib217","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000426","article-title":"Structure of the CaMKII\u03b4\/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation","volume":"8","author":"Rellos","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmr.2025.100064_bib218","doi-asserted-by":"crossref","first-page":"42006","DOI":"10.1074\/jbc.M304238200","article-title":"\u03b3-Hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABAB receptor activation in mouse frontal cortex and hippocampus","volume":"278","author":"Ren","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib219","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2006.03.056","article-title":"gamma-Hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: an involvement of GABAB receptors and cAMP-dependent protein kinase activation","volume":"141","author":"Ren","year":"2006","journal-title":"Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib220","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2023.12.016","article-title":"Role of CAMK2D in neurodevelopment and associated conditions","volume":"111","author":"Rigter","year":"2024","journal-title":"Am J Hum Gen"},{"key":"10.1016\/j.pharmr.2025.100064_bib221","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2017.09.010","article-title":"Memory erasure experiments Indicate a critical role of CaMKII in memory storage","volume":"96","author":"Rossetti","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib222","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuint.2017.01.002","article-title":"Ischaemia- and excitotoxicity-induced CaMKII-mediated neuronal cell death: the relative roles of CaMKII autophosphorylation at T286 and T253","volume":"104","author":"Rostas","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib223","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/0006-2952(70)90087-0","article-title":"Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib224","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0028-3908(66)90007-4","article-title":"Gamma-butyrolactone and gamma-hydroxybutyric acid. II. The pharmacologically active form","volume":"5","author":"Roth","year":"1966","journal-title":"Int J Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-2952(69)90032-X","article-title":"Conversion in vivo of gamma-aminobutyric to gamma-hydroxybutyric acid in the rat","volume":"18","author":"Roth","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib226","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0006-2952(70)90370-9","article-title":"Natural occurrence of \u03b3-hydroxybutyrate in mammalian brain","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0014-5793(81)80559-5","article-title":"Evidence that a specific succinic semialdehyde reductase is responsible for \u03b3-hydroxybutyrate synthesis in brain tissue slices","volume":"134","author":"Rumigny","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib228","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","article-title":"Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study","volume":"152","author":"Russell","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2025.100064_bib229","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1021\/jm1006325","article-title":"Design, synthesis and in vitro pharmacology of new radiolabelled GHB analogues including photolabile analogues with irreversible binding to the high-affinity GHB binding sites","volume":"53","author":"Sabbatini","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1196\/annals.1369.054","article-title":"\u03b3-Hydroxybutyrate (GHB), \u03b3-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion","volume":"1074","author":"Sadasivan","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib231","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.100.3.835","article-title":"Phosphorylation-dependent subcellular translocation of a Ca2+\/calmodulin-dependent protein kinase produces an autonomous enzyme in Aplysia neurons","volume":"100","author":"Saitoh","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100064_bib232","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2019.04.012","article-title":"Reciprocal activation within a kinase-effector complex underlying persistence of structural LTP","volume":"102","author":"Saneyoshi","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib233","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(99)00066-4","article-title":"Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain","volume":"21","author":"Schmidt-Mutter","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib234","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/08830738211012804","article-title":"A Randomized controlled trial of SGS-742, a gamma-aminobutyric acid B (GABA-B) receptor antagonist, for succinic semialdehyde dehydrogenase deficiency","volume":"36","author":"Schreiber","year":"2021","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pharmr.2025.100064_bib235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/jpet.104.069534","article-title":"\u03b3-Hydroxybutyrate increases a potassium current and decreases the H-current in hippocampal neurons via GABAB receptors","volume":"311","author":"Schweitzer","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib236","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1016\/S0021-9258(18)68264-X","article-title":"Ca2+\/calmodulin-dependent protein kinase II. Identification of a regulatory autophosphorylation site adjacent to the inhibitory and calmodulin-binding domains","volume":"263","author":"Schworer","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib237","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0306-4522(99)00586-2","article-title":"Subcellular distribution and autophosphorylation of calcium\/calmodulin-dependent protein kinase II-alpha in rat hippocampus in a model of ischemic tolerance","volume":"96","author":"Shamloo","year":"2000","journal-title":"Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib238","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0896-6273(00)80569-3","article-title":"CaMKII\u03b2 functions as an F-actin targeting module that localizes CaMKII\u03b1\/\u03b2 heterooligomers to dendritic spines","volume":"21","author":"Shen","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100064_bib239","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/jcbfm.2012.124","article-title":"\u03b1CaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity","volume":"32","author":"Skelding","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib240","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz0240","article-title":"Heterogeneity in human hippocampal CaMKII transcripts reveals allosteric hub-dependent regulation","volume":"13","author":"Sloutsky","year":"2020","journal-title":"Sci Signal"},{"key":"10.1016\/j.pharmr.2025.100064_bib241","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1471-4159.1987.tb13147.x","article-title":"\u03b3-Hydroxybutyric acid in subcellular fractions of rat brain","volume":"48","author":"Snead","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib242","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-2999(92)90623-C","article-title":"Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures","volume":"213","author":"Snead","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib243","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(94)90874-5","article-title":"The ontogeny of [3H]\u03b3-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures","volume":"659","author":"Snead","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib244","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(95)00200-6","article-title":"Antiabsence seizure activity of specific GABAB and \u03b3-hydroxybutyric acid receptor antagonists","volume":"53","author":"Snead","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2025.100064_bib245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM198101083040206","article-title":"Concentration of \u03b3-hydroxybutyric acid in ventricular and lumbar cerebrospinal fluid","volume":"304","author":"Snead","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100064_bib246","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/0006-2952(89)90645-X","article-title":"In vivo conversion of \u03b3-aminobutyric acid and 1,4-butanediol to \u03b3-hydroxybutyric acid in rat brain. Studies using stable isotopes","volume":"38","author":"Snead","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib247","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","article-title":"Gamma-hydroxybutyric acid","volume":"352","author":"Snead","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100064_bib248","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0165-3806(81)90010-9","article-title":"Ontogeny of gamma-hydroxybutyric acid. I. Regional concentration in developing rat, monkey and human brain","volume":"227","author":"Snead","year":"1981","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib249","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0006-2952(96)00477-7","article-title":"Relation of the [3H] \u03b3-hydroxybutyric acid (GHB) binding site to the \u03b3-aminobutyric acidB (GABAB) receptor in rat brain","volume":"52","author":"Snead","year":"1996","journal-title":"Biochem Pharm"},{"key":"10.1016\/j.pharmr.2025.100064_bib250","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1471-4159.2000.0751986.x","article-title":"Evidence for a G protein-coupled \u03b3-hydroxybutyric acid receptor","volume":"75","author":"Snead","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib251","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/0006-2952(84)90629-4","article-title":"Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes","volume":"33","author":"Snead","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib252","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0028-3908(87)90173-0","article-title":"\u03b3-Hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel","volume":"26","author":"Snead","year":"1987","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib253","doi-asserted-by":"crossref","DOI":"10.1186\/ar4375","article-title":"Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia","volume":"15","author":"Spaeth","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib254","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1471-4159.1971.tb09588.x","article-title":"Stimulation of brain dopamine synthesis by \u03b3-hydroxybutyrate","volume":"18","author":"Spano","year":"1971","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib255","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1517\/14656566.2011.589836","article-title":"Sodium oxybate for the treatment of fibromyalgia","volume":"12","author":"Staud","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100064_bib256","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1523\/JNEUROSCI.2068-16.2017","article-title":"A novel human CAMK2A mutation disrupts dendritic morphology and synaptic transmission, and causes ASD-related behaviors","volume":"37","author":"Stephenson","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib257","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1074\/jbc.273.33.20689","article-title":"Autophosphorylation-dependent targeting of calcium\/ calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl- D-aspartate receptor","volume":"273","author":"Strack","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib258","doi-asserted-by":"crossref","first-page":"23798","DOI":"10.1074\/jbc.M001471200","article-title":"Mechanism and regulation of calcium\/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor","volume":"275","author":"Strack","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib259","article-title":"Activation-triggered subunit exchange between CaMKII holoenzymes facilitates the spread of kinase activity","volume":"3","author":"Stratton","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100064_bib260","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216529119","article-title":"Start spreading the news! CaMKII shares activity with naive molecules","volume":"119","author":"Stratton","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib261","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.drugalcdep.2007.07.009","article-title":"Use, function, and subjective experiences of \u03b3-hydroxybutyrate (GHB)","volume":"92","author":"Sumnall","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2025.100064_bib262","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tiv.2015.11.020","article-title":"Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: possible role in drug induced liver injury (DILI)","volume":"31","author":"Syed","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.pharmr.2025.100064_bib263","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2003.12.013","article-title":"Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons","volume":"55","author":"Szabo","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100064_bib264","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-4522(02)00451-7","article-title":"Calcium\/calmodulin-dependent protein kinase II clusters in adult rat hippocampal slices","volume":"115","author":"Tao-Cheng","year":"2002","journal-title":"Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib265","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1073\/pnas.85.17.6337","article-title":"Ca2+\/calmodulin-dependent protein kinase II: identification of threonine-286 as the autophosphorylation site in the alpha subunit associated with the generation of Ca2+-independent activity","volume":"85","author":"Thiel","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100064_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105203","article-title":"The \u03b3-hydroxybutyric acid (GHB) analogue NCS-382 is a substrate for both monocarboxylate transporters subtypes 1 and 4","volume":"143","author":"Thiesen","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib267","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jnc.14649","article-title":"Lack of evidence for synaptic high-affinity \u03b3-hydroxybutyric acid (GHB) transport in rat brain synaptosomes and 11 Na+ -dependent SLC neurotransmitter transporters","volume":"149","author":"Thiesen","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib268","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/jpet.115.224543","article-title":"In vitro and in vivo evidence for active brain uptake of the GHB analog HOCPCA by the monocarboxylate transporter subtype 1","volume":"354","author":"Thiesen","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib269","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/acs.jmedchem.1c02177","article-title":"Discovery and optimization of 5-hydroxy-diclofenac toward a new class of ligands with nanomolar affinity for the CaMKIIa hub domain","volume":"65","author":"Tian","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib270","doi-asserted-by":"crossref","first-page":"15066","DOI":"10.1021\/acs.jmedchem.2c00805","article-title":"Exploring the NCS-382 scaffold for CaMKIIa modulation: Synthesis, biochemical pharmacology, and biophysical characterization of Ph-HTBA as a novel high-affinity brain-penetrant stabilizer of the CaMKIIa hub domain","volume":"65","author":"Tian","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib271","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.forsciint.2017.01.015","article-title":"Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment","volume":"274","author":"Tittarelli","year":"2017","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib272","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2003.08.023","article-title":"Organization and evolution of multifunctional Ca2+\/CaM-dependent protein kinase genes","volume":"322","author":"Tombes","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100064_bib273","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/pro.3869","article-title":"Characterization of CaMKII\u03b1 holoenzyme stability","volume":"29","author":"Torres-Ocampo","year":"2020","journal-title":"Protein Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib274","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1021\/acschemneuro.9b00336","article-title":"DARK classics in chemical neuroscience: gamma-hydroxybutyrate (GHB)","volume":"11","author":"Trombley","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib275","first-page":"278","article-title":"\u03b3-Hydroxybutyrate (orphan medical)","volume":"3","author":"Tunnicliff","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmr.2025.100064_bib276","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI119587","article-title":"Simultaneous stimulation of slow-wave sleep and growth hormone secretion by \u03b3-hydroxybutyrate in normal young men","volume":"100","author":"Van Cauter","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100064_bib277","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0197-0186(88)90148-9","article-title":"Gamma hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat","volume":"12","author":"Vayer","year":"1988","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib278","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(88)90152-8","article-title":"Regional differences in depolarization-induced release of \u03b3-hydroxybutyrate from rat brain slices","volume":"87","author":"Vayer","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100064_bib279","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-4159.1985.tb04065.x","article-title":"Conversion of \u03b3-hydroxybutyrate to \u03b3-aminobutyrate in vitro","volume":"45","author":"Vayer","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100064_bib280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(00)00246-6","article-title":"Neuroprotective effect of \u03b3-hydroxybutyrate in transient global cerebral ischemia in the rat","volume":"397","author":"Vergoni","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib281","doi-asserted-by":"crossref","first-page":"20675","DOI":"10.1074\/jbc.M109.088617","article-title":"Effective post-insult neuroprotection by a novel Ca2+\/ calmodulin-dependent protein kinase II (CaMKII) inhibitor","volume":"285","author":"Vest","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib282","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1523\/JNEUROSCI.3145-10.2010","article-title":"Differential effects of GABAB receptor subtypes, \u03b3-hydroxybutyric acid, and baclofen on EEG activity and sleep regulation","volume":"30","author":"Vienne","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib283","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10545-012-9499-5","article-title":"Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism","volume":"36","author":"Vogel","year":"2013","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.pharmr.2025.100064_bib284","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1021\/jm4011719","article-title":"New synthesis and tritium labeling of a selective ligand for studying high-affinity gamma-hydroxybutyrate (GHB) binding sites","volume":"56","author":"Vogensen","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100064_bib285","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1523\/JNEUROSCI.21-02-00423.2001","article-title":"Densin-180 forms a ternary complex with the (alpha)-subunit of Ca2+\/calmodulin-dependent protein kinase II and (alpha)-actinin","volume":"21","author":"Walikonis","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100064_bib286","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0304-4165(64)90107-2","article-title":"Metabolism of \u03b3-hydroxybutyric acid","volume":"86","author":"Walkenstein","year":"1964","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100064_bib287","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11095-006-9228-6","article-title":"Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells","volume":"24","author":"Wang","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2025.100064_bib288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004647-199601000-00001","article-title":"Ischemia-induced neuronal damage: a role for calcium\/calmodulin-dependent protein kinase II","volume":"16","author":"Waxham","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100064_bib289","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00213-004-2079-0","article-title":"Spontaneous and precipitated withdrawal after chronic intragastric administration of \u03b3-hydroxybutyrate (GHB) in baboons","volume":"179","author":"Weerts","year":"2005","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.pharmr.2025.100064_bib290","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-0186(82)90041-9","article-title":"Immunocytochemical localization in rat brain of the enzyme that synthesizes \u03b3-hydroxybutyric acid","volume":"4","author":"Weissmann-Nanopoulos","year":"1982","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100064_bib291","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.105.090472","article-title":"Novel cyclic \u03b3-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain","volume":"315","author":"Wellendorph","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib292","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.110.170670","article-title":"Novel radioiodinated GHB analogues for radiolabeling and photolinking of high-affinity GHB binding sites","volume":"335","author":"Wellendorph","year":"2010","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib293","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1472-8206.2008.00664.x","article-title":"Phenylacetic acids and the structurally related non-steroidal anti-inflammatory drug (NSAID) diclofenac bind to specific \u03b3-hydroxybutyric acid (GHB) sites in rat brain","volume":"23","author":"Wellendorph","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100064_bib294","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2013.12.067","article-title":"Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death","volume":"263","author":"Wendt","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2025.100064_bib295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug \u03b3-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100064_bib296","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jmb.2019.02.001","article-title":"The KN-93 molecule inhibits calcium\/calmodulin-dependent protein kinase II (CaMKII) activity by binding to Ca2+\/CaM","volume":"431","author":"Wong","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100064_bib297","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.102.046797","article-title":"A tertiary alcohol analog of \u03b3-hydroxybutyric acid as a specific \u03b3-hydroxybutyric acid receptor ligand","volume":"305","author":"Wu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100064_bib298","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(92)90347-7","article-title":"Gamma-hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors","volume":"212","author":"Xie","year":"1992","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:58:27Z","timestamp":1759964307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699725074721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":298,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0031699725074721"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100064","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Union of Basic and Clinical Pharmacology. CXX. \u03b3-Hydroxybutyrate protein targets in the mammalian brain\u2014beyond classic receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100064"}}